GE HealthCare investing $80M in contrast media ingredients plant in Norway

By Danielle Kirsh | November 17, 2022

GE Healthcare image illustrating contrast media uses

GE Healthcare says its contrast media products are used in more than 100 million procedures globally every year. [Image courtesy of GE Healthcare]

GE HealthCare today announced it is investing $80 million to expand contrast media production capacity in Norway.

The investment will go toward increasing manufacturing capacity by 30% at its active pharmaceutical ingredients site in Lindesnes, Norway. As a result, the investment will create around 100 new jobs.

GE HealthCare officials have committed to addressing the significant global demand for iodinated contrast media. The media enables a host of X-ray and computed tomography (CT) procedures around the world.

Get the full story on our sister site, MassDevice.

About The Author

Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].